Literature DB >> 11290439

Melanoma cells stimulate osteoclastogenesis, c-Src expression and osteoblast cytokines.

M Perez1, S Migliaccio, A Taranta, C Festuccia, L Orrù, M Brama, M Bologna, T Faraggiana, R Baron, A Teti.   

Abstract

Malignant melanomas metastasise to the bone and enhance osteoclast bone resorption. We demonstrated that a 48-h-B16 melanoma cell conditioned media (B16CM) induced osteoclastogenesis in mouse bone marrow cultures, without the requirement of B16 cell-bone marrow cell co-culture. B16 cells transcriptionally expressed detectable levels of TGFbeta1, IL-6, M-CSF, GM-CSF and TNFalpha mRNAs, albeit to a lower extent compared with levels in osteoblasts, and failed to express PTHrP, OPGL, OPG and IL-1beta. Interestingly, B16CM greatly upregulated IL-1beta, IL-6 and GM-CSF, and modestly enhanced TNFalpha and OPGL mRNA expression in osteoblasts, suggesting a potential indirect stimulation of osteoclastogenesis via the osteogenic lineage. B16CM barely upregulated c-Fos, but strongly and time-dependently enhanced c-Src expression in the total bone marrow cultures during osteoclast differentiation. Moreover, c-Src expression was enhanced in differentiated and purified osteoclast preparations to higher levels than in stromal cells. In conclusion, melanoma induces osteoclast generation with a paracrine mechanism independent of cell-cell contact, specifically upregulating c-Src in osteoclasts and cytokine expression in osteoblasts.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11290439     DOI: 10.1016/s0959-8049(00)00436-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  5 in total

1.  RANK, RANKL and OPG Expression in Breast Cancer - Influence on Osseous Metastasis.

Authors:  J T Ney; T Fehm; I Juhasz-Boess; E F Solomayer
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-05       Impact factor: 2.915

2.  Vascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow microenvironment via tumor cyclooxygenase-2.

Authors:  María Valcárcel; Lorea Mendoza; José-Julio Hernández; Teresa Carrascal; Clarisa Salado; Olatz Crende; Fernando Vidal-Vanaclocha
Journal:  J Transl Med       Date:  2011-08-25       Impact factor: 5.531

3.  Malignant melanoma and bone resorption.

Authors:  Y S Lau; A Sabokbar; H Giele; V Cerundolo; W Hofstetter; N A Athanasou
Journal:  Br J Cancer       Date:  2006-05-22       Impact factor: 7.640

4.  Martini: using literature keywords to compare gene sets.

Authors:  Theodoros G Soldatos; Seán I O'Donoghue; Venkata P Satagopam; Lars J Jensen; Nigel P Brown; Adriano Barbosa-Silva; Reinhard Schneider
Journal:  Nucleic Acids Res       Date:  2009-10-25       Impact factor: 16.971

5.  XPO1/CRM1-selective inhibitors of nuclear export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa).

Authors:  Giovanni Luca Gravina; Monica Tortoreto; Andrea Mancini; Alessandro Addis; Ernesto Di Cesare; Andrea Lenzi; Yosef Landesman; Dilara McCauley; Michael Kauffman; Sharon Shacham; Nadia Zaffaroni; Claudio Festuccia
Journal:  J Hematol Oncol       Date:  2014-10-05       Impact factor: 17.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.